German $10 bln publisher IPO is buyout exit test
The author is a Reuters Breakingviews columnist. The opinions expressed are her own.
By Yawen Chen
LONDON, Sept 12 (Reuters Breakingviews) -Springer Nature’s fourth attempt at going public will set the bar for buyout barons stuck on the way out. The German academic research publisher on Thursday announced its intention to float in Frankfurt, over a decade after private equity owner BC Partners bought in. The risk is the initial public offering sweeteners prove insufficient to convince cautious investors staring at the precarious German economy.
Springer Nature’s path out of private ownership has been rocky. The company had to scrap its last listing attempt in 2020, which ambitiously sought to raise nearly 1 billion euros ($1.1 billion) during Covid-19. There were also fears that increasingly popular open-access journals would erode revenue from expensive subscriptions. The company eventually had to resort to a private change of hands in 2021 between funds controlled by BC Partners, which holds a 47% stake.
This time around, Springer Nature looks less dog-eared. The open-access model still means it collects fees from universities and research institutes. Adjusted revenue grew 5% last year, and operating profit has inched up by 1 percentage point annually since 2019. As a result, Springer Nature’s much-frowned debt burden has more than halved to 2.7 times EBITDA. Prospective IPO investors will get an annual dividend equaling 50% of adjusted net income on a permanent basis.
As such, there’s a way for the group to be worth 9 billion euros ($10 billion), as bankers hope. In 2023 Springer Nature made around 685 million euros of EBITDA, Breakingviews calculates from conversations with a source familiar with the situation. On a multiple of 16 – the average of rivals Wiley WLY.N, Wolters Kluwer WLSNc.AS, RELX REL.L and Informa INF.L – it would be worth 9.1 billion euros, after stripping out 1.85 billion euros of net debt.
Yet that ignores the need for a discount for factors such as Springer Nature’s relatively higher leverage to its peer group. The research publishing sector is also only expected to grow at a compound annual growth rate of around 3% between 2023 and 2029. And IPO markets are moribund – in the first half they raised their lowest volume since 2016, Dealogic data shows.
Either way buyout shops are sitting on more than $3 trillion of portfolio companies, and have held onto them for an uncomfortably long median of over five years, per research shop Preqin. Springer Nature could raise its chances of success via a smaller fund-raising target of around 500 million euros. If a float can get away at the desired valuation level, it will give some glum private equity types some reason to be cheerful.
Follow @ywchen1 on X
CONTEXT NEWS
Springer Nature said on Sept. 12 it plans to launch an initial public offering (IPO) on the Frankfurt Stock Exchange that could be completed by the end of 2024.
The company said its planned IPO will consist of a 200-million-euro ($220 million) capital increase and a sale of existing shares. It intends to pay a dividend of 25 million euros ($27.5 million) for this year, and thereafter an annual dividend of around 50% of annual adjusted net income.
Holtzbrinck Publishing Group and BC Partners currently own 53% and 47% stakes respectively.
Reuters reported in February an IPO could value the company at up to 9 billion euros including debt.
IPOs have been broadly lagging stock markets https://reut.rs/4gpP3De
Editing by George Hay and Streisand Neto
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
